Filipa Costa returned to Portugal in September 2016 to take on the leadership of the fastest growing multinational affiliate in the country - Janssen.…

Mark Hicken, managing director of the UK and Ireland operations of Janssen, the pharmaceutical arm of Johnson & Johnson, highlights the…

A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other developed European markets, with a…

Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring…

When combining the sheer size of Brazil - the fifth largest country in the world - with its tropical climate, its largely perfectible infrastructure,…

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of…

A passionate advocate for Indian patients, Sanjiv Navangul, managing director of Janssen India, discusses the company’s public health work in the…

With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to the country’s vast population, two…

Bruno Costa Gabriel, managing director of Janssen Brazil, provides insights into the transformative market approach successfully implemented by this…

With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for…

Yolanda Alagón, general manager of Janssen Colombia, discusses the company's footprint in Colombia and Latin America and her strategy for the…

Efthymios (Makis) Papataxiarchis, Managing Director of Janssen Pharmaceutical companies, Johnson & Johnson Greece, Malta & Cyprus, on…